• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    SARS-CoV-2 R&D: Is It Over?

    Sustainability: A New Threat or Opportunity for CDMOs?

    Advanced Therapy Manufacturing

    Advanced Therapy Packaging Trends

    CEO Spotlight: Darren Head
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Piramal Pharma Solutions New API Plant in Canada Now Online

    MG America Appoints Claudio Radossi as President

    Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY

    Sartorius Expands Manufacturing Site in Tunisia

    BioMoti Partners with Pharma Company to Develop Ovarian Cancer Treatment
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Piramal Pharma Solutions New API Plant in Canada Now Online

    Selecting a CMO Partner for Sterile Injectable Manufacturing

    Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY

    Grand Opening of Kodiak Sciences’ Bioconjugation Facility

    Vertex Expands Cell and Gene Therapy Footprint
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Selecting a CMO Partner for Sterile Injectable Manufacturing

    Royalty Pharma and Jefferies Invest $111M in ApiJect

    Cryoport Acquires Cell&Co BioServices for €6.2M

    Challenges of Developing Large Volume Drug/Device Combination Products for Parenteral SC Delivery

    Yourway Adds Capacity for Controlled Ambient Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Selecting a CMO Partner for Sterile Injectable Manufacturing

    BioMoti Partners with Pharma Company to Develop Ovarian Cancer Treatment

    WCG Appoints Sam Srivastava CEO

    AffyXell Expands Manufacturing Partnership with GenScript ProBio

    ABL and Odimma Therapeutics Enter Development Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    FDA Inspection Trends Update

    Phase-Appropriate cGMP Considerations for Cell and Gene Therapy

    Sustainability: A New Threat or Opportunity for CDMOs?

    In Pursuit of Sustainability: How the Biopharma Industry Can Contribute

    Conducting Clinical Trials During the Pandemic: What Did We Learn?
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Quotient Sciences

    Alcami

    Vector Partners Limited

    Aphena Pharma Solutions

    Kyongbo Pharmaceutical
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Quotient Sciences

    Alcami

    Vector Partners Limited

    Aphena Pharma Solutions

    Kyongbo Pharmaceutical
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Solid Dose Market Trends

    A Q&A with Mark DaFonseca, chief business officer at CoreRx.

    Solid Dose Market Trends
    An external view of the CoreRx headquarters in Clearwater, Florida.
    Related CONTENT
    • Bora Pharmaceuticals
    • CoreRx
    • Legacy Pharma Solutions
    • Sensum
    • DPT
    Tim Wright, Editor, Contract Pharma02.26.21
    CoreRx is a contract development and manufacturing organization (CDMO) with capabilities to support clinical through commercial manufacturing. Its integrated offerings provide comprehensive services for the development, manufacturing, and testing of solid, liquid and semi-solid dosage forms. Contract Pharma recently spoke with Mark DaFonseca, chief business officer at CoreRx about oral solid dose market and technology trends.
     
    Contract Pharma: How would you describe the current state of the oral solid dose manufacturing market?
     
    Mark DaFonseca: The oral solid dosage market is still strong. It is still one of the most patient friendly dosage forms available. About 60% of the projects we do are oral solid dose, and this has been fairly consistent for the last 5 years. The focus is primarily on small molecules however, we have seen an increase in the need for oral solid dosage forms for proteins and peptides.

    Contract Pharma: What’s new on the oral solid dosage front at CoreRx?

    DaFonseca: CoreRx has been continuing to invest in our campus in Clearwater, FL. We doubled our manufacturing capacity in 2019 by building out a portion of our ML2 building for small scale manufacturing and packaging, allowing our ML1 building to be focused on larger scale manufacturing and packaging for late phase and commercial programs. ML1 becomes the second building on our campus that we perform commercial manufacturing in, as our third building, ML3, is dedicated to one our clients for commercial manufacturing and testing.


    A rendering of the new CoreRx campus in Clearwater, FL. Headquarters are located at ML1.

    In 2020, we completed an expansion into our new 26,000 sq. ft. Product Development Center of Excellence where we support solid dosage form development, as well as have a dedicated lab for in vitro screening of drug permeability. In addition, we recently brought online our new Mobile Minor unit to continue supporting cGMP manufacturing of spray dried dispersions as part of our bioavailability enhancement technologies.
     
    We feel we have positioned CoreRx now as a premier CDMO that can support clients from early phase through commercial manufacturing, offering end to end solutions across a variety of technologies on a single campus. Providing the small Pharma sector the development expertise, speed and flexibility they need, in a CDMO they can now stay with for commercial support, is something we have seen great interest in from the market.

    Contract Pharma: What are some key trends driving the contract solid dosage business?

    DaFonseca: In 2020, there was a push to get non-vaccine products for treating hospitalized patients with Covid into the clinic. We were fortunate enough to have at least one of those products successfully complete Phase I and move into Phase II. There is in general still a large need for pediatric dosage forms. While most of these are oral liquid dosage forms, there is a lot of interest in alternative dosage forms such as dispersible tablets, mini-tablets, and sachets. 

    We also saw more projects than ever starting with either a powder in capsule or powder in bottle for reconstitution approach for Phase I. It seems the whole market has decided this is the fastest way to get into the clinic. And while this may be true, it isn’t necessarily the best way to go for products with special needs such as a high dose, delayed or extended release. In the long term, it pays to get some formulation work done towards a final dosage form early in the process.  
     
    Contract Pharma: Where are the current opportunities for growth?
     
    DaFonseca: There is still an unmet demand in bioavailability enhancement of molecules. Having a variety of formulation and technology approaches to help solve those problems, and tools to assess their effectiveness, will allow an organization to set themselves apart. We are increasingly using in vitro permeability screening to identify the factors important for a products bioavailability. 
     
    Contract Pharma: Conversely, what are the challenges and/or obstacles in the market?
     
    DaFonseca: One of the major challenges we are experiencing since the pandemic hit last year is significant delays in the receipt of raw materials and packaging components. A lot of resources got diverted to Covid activities making it a challenge to get projects started and keep to original timelines. Getting sufficient active ingredient (API) to work with during development remains a challenge as does getting a consistent API to work with. Polymorphic and morphologic changes of the API during scale-up are a constant problem that we face.
     
    Contract Pharma: What are the most recent advances in oral solid drug delivery technology?
     
    DaFonseca: Spray granulating of nanoparticles, spray congealing of lipid particles, microfluidization, and hot melt granulation are some of the techniques we’ve been able to put into practice to improve bioavailability.
     


    Mark DaFonseca, Chief Business Officer, CoreRx
    Suggested For You
    Bora Pharmaceuticals Bora Pharmaceuticals
    CoreRx CoreRx
    Legacy Pharma Solutions Legacy Pharma Solutions
    Sensum Sensum
    DPT DPT
    Aenova Aenova
    W. R. Grace FCMS W. R. Grace FCMS
    Ackley Machine Corporation Ackley Machine Corporation
    PCI Pharma Services PCI Pharma Services
    PCI Synthesis PCI Synthesis
    Seqens CDMO North America Seqens CDMO North America
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
    Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate  Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
    Clean Cells Expands Bioproduction Capabilities Clean Cells Expands Bioproduction Capabilities

    Related Content

    • Bora Pharmaceuticals

      Bora Pharmaceuticals

      ...
      Lonnie Barish, VP, Business Development 03.09.22

    • Analytical Services | Formulation Development | Logistics
      CoreRx

      CoreRx

      ...
      MICHELLE HALL, CORERX, INC. 01.28.22

    • Legacy Pharma Solutions

      Legacy Pharma Solutions

      ...
      Nathan Bender, Director, Sales & Marketing 12.07.21


    • Sensum

      ...
      Marko Sraj, BDM 12.06.21

    • R&D
      DPT

      DPT

      With a specialized focus on semi-solids and liquids, DPT offers pharmaceutical companies the broadest range of capabilities in the industry. From R&D formulation to commercial-scale manufacturing, small batches to large, liquids to emulsions, sterile or non-sterile, we offer clients of all sizes the most effective resources for meeting challenges.
      Stacy London, Senior Manager, Marketing & Communications 12.02.21

      Trending
      • Catalent Invests $175M To Expand Mfg. Capabilities At Winchester, KY | Contract Pharma
      • Sartorius Expands Manufacturing Site In Tunisia | Contract Pharma
      • Grand Opening Of Kodiak Sciences’ Bioconjugation Facility | Contract Pharma
      • Vertex Expands Cell And Gene Therapy Footprint | Contract Pharma
      • Emergex COVID-19 Vaccine Candidate Successfully Coated Onto Zosano Micro-Needle Patch | Contract Pharma
      Breaking News
      • Piramal Pharma Solutions New API Plant in Canada Now Online
      • MG America Appoints Claudio Radossi as President
      • Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY
      • Sartorius Expands Manufacturing Site in Tunisia
      • BioMoti Partners with Pharma Company to Develop Ovarian Cancer Treatment
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Sustainability and the Biopharma Industry
      • Contract Manufacturing During COVID
      • Orphan Drugs in the United States
      • CEO Spotlight: Peter DeYoung
      • CEO Spotlight: Darren Head
      • Advanced Therapy Packaging Trends
      • Advanced Therapy Manufacturing
      • Sustainability: A New Threat or Opportunity for CDMOs?
      • SARS-CoV-2 R&D

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      Coatings World

      Latest Breaking News From Coatings World

      Teknos Receives EcoVadis Gold Medal for Sustainability Performance
      AkzoNobel and Partners Team Up to Hack Carbon Reduction Challenges
      Five PPG Facilities in Ohio Recognized for Sustainability, Health, Safety Practices
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Iterative Scopes Expands its Senior Leadership Team
      Viz.ai Raises $100 Million in Series D Funding
      FDA Clears Arterys' AI Mapping and Quantification Tools
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Piramal Pharma Solutions New API Plant in Canada Now Online
      MG America Appoints Claudio Radossi as President
      Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Authentic Beauty Concept Launches Second-Generation ‘Refill Bar’
      HASK Beauty Enters Exclusive Partnership with Amazon
      Garance Doré Launches Made in France Skincare Line
      Happi

      Latest Breaking News From Happi

      SPF Setting Spray, Lip Contour and Knotless Braids Are Hot Trends: Spate
      Nutrafol Launches Collagen Infusion
      ÄZ Craft Luxury Haircare Products Support All Hairstyles
      Ink World

      Latest Breaking News From Ink World

      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Award for Sustainability: Evonik Receives Platinum Rating Again
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Specialty announces move to new facility
      Mark Andy hosts dealer's open house in Warsaw
      Nazdar celebrates 100th anniversary with refreshed brand identity
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      3M to Expand in Nebraska
      Nicely Offers Nonwoven Slitters, Winders
      'Right' Hygiene Conference to be Held in June
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair
      Cionic Expands Scientific Advisory Board
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell
      eMagin Wins People’s Choice Award at Display Week 2022

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login